We continually innovate and are committed to providing our clients with certified, best-in-class technology. We also offer a team of Meaningful Use Advisors, including Certified Meaningful Use Professionals, as well as a number of digital resources, to help answer your Meaningful Use questions.

Flatiron Health OncoEMR® version 2.8 is ONC Health IT 2015 Edition compliant (Product Number: 15.04.04.3010.Onco.28.01.1.181214; certified on December 14, 2018).


OncoEMR® has certified the below functionality against the ONC 2015 requirements based on the test methods and tools noted in the parentheticals.

Criteria:

170.315 (a)(1): Computerized Provider Order Entry (CPOE) – Medications (ONC Test Method; Version 1.1), 170.315 (a)(2): CPOE – Laboratory (ONC Test Method; Version 1.1), 70.315 (a)(3): CPOE – Diagnostic Imaging (ONC Test Method; Version 1.1), 170.315 (a)(4): Drug-Drug, Drug-Allergy Interaction Checks for CPOE (ONC Test Method; Version 1.1), 170.315 (a)(5): Demographics (ONC Test Method; Version 1.5), 170.315 (a)(9): Clinical Decision Support (ONC Test Method; Version 1.3), 170.315 (a)(10): Drug-Formulary and Preferred Drug List Checks (ONC Test Method; Version 1.1), 170.315 (a)(12): Family Health History (ONC Test Method; Version 1.1), 170.315 (a)(13): Patient-Specific Education Resources (ONC Test Method; Version 1.1), 170.315 (a)(14): Implantable Device List (ONC Test Method; Version 1.3), 170.315 (b)(1): Transitions of Care (ONC Test Method; Version 2.3; Edge Testing Tool; Version 2.3.1; Alteration: N/A), 170.315 (b)(2): Clinical Information Reconciliation and Incorporation (ONC Test Method; Version 2.3; Edge Testing Tool; Version 2.3.1; Alteration: N/A), 170.315 (b)(3): Electronic Prescribing (ONC Test Method; Version 1.1; Electronic Prescribing; Version 1.2.32; Alteration: N/A), 170.315 (b)(6): Data Export (ONC Test Method; Version 1.0; Edge Testing Tool; Version 2.3.1; Alteration: N/A), 170.315 (c)(1): Clinical Quality Measures – Record and Export (ONC Test Method; Version 1.6; Cypress; Version 3.2.3; Alteration: N/A), 170.315 (d)(1): Authentication, Access Control, Authorization (ONC Test Method; Version 1.1), 170.315 (d)(2): Auditable Events and Tamper-Resistance (ONC Test Method; Version 1.3), 170.315 (d)(3): Audit Report(s) (ONC Test Method; Version 1.3), 170.315 (d)(4): Amendments (ONC Test Method; Version 1.1), 170.315 (d)(5): Automatic Access Time-out (ONC Test Method; Version 1.1), 170.315 (d)(6): Emergency Access (ONC Test Method; Version 1.1), 170.315 (d)(7): End-User Device Encryption (ONC Test Method; Version 1.1), 170.315 (d)(8): Integrity (ONC Test Method; Version 1.1), 170.315 (d)(9): Trusted Connection (ONC Test Method; Version 1.1), 170.315 (d)(11): Accounting of Disclosures (ONC Test Method; Version 1.1), 170.315 (e)(1): View, Download, and Transmit to 3rd Party (ONC Test Method; Version 1.5; Edge Testing Tool; Version 2.3.1; Test Data Version 1.4; Alteration: N/A), 170.315 (e)(2): Secure Messaging (ONC Test Method; Version 1.1), 170.315 (e)(3): Patient Health Information Capture (ONC Test Method; Version 1.1), 170.315 (f)(1): Transmission to Immunization Registries (ONC Test Method; Version 1.1; HIMSS Immunization Integration Program; Version 1.0; HL7v2 Immunization Test Suite; Version 1.8.0; Alteration: N/A), 170.315(f)(4): Transmission to Cancer Registries (ONC Test Method; Version 1.0; HL7 CDA Cancer Registry Reporting Validation Tool; Version 1.0.5; Alteration: N/A) 170.315 (g)(2): Automated Measure Calculation (ONC Test Method; Version 1.6), 170.315 (g)(3): Safety-Enhanced Design (ONC Test Method; Version 1.1), 170.315 (g)(4): Quality Management System (ONC Test Method; Version 1.0), 170.315 (g)(5): Accessibility-Centered Design (ONC Test Method; Version 1.0), 170.315 (g)(6): Consolidated CDA Creation (ONC Test Method; Version 1.0; Edge Testing Tool; Version 2.3.1; Alteration: N/A), 170.315 (g)(7): Application Access – Patient Selection (ONC Test Method; Version 1.1), 170.315 (g)(8): Application Access – Data Category Request (ONC Test Method; Version 1.1), 170.315 (g)(9): Application Access – All Data Request (ONC Test Method; Version 1.1; Edge Testing Tool; Version 2.3.1; Alteration: N/A)


 

OncoEMR® has certified the below CQM’s for use of ONC 2015 certified technology.

CQMs:

CMS68: Documentation of Current Medications in the Medical Record

See Certificate of Health IT Compliance.

OncoEMR® is 2015 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

OncoEMR® requires a one-time implementation fee for installation plus annual subscription fees which cover software licenses, customer support, software upgrades and services required to meet Promoting Interoperability objectives and measures. Use of HL7 interfaces in OncoEMR may also require an additional one-time implementation fee and an additional annual subscription fee for maintenance. Data conversions may also require an additional one-time fee depending on the volume of data being converted. We have also partnered with MaxMD to help users deliver electronic referrals and DrFirst for controlled substance e-prescribing functionality in OncoEMR. Please note that there are additional one-time and/or annual vendor fees associated with the use of these services.



Mandatory Disclosure:

The data that’s exposed to the practice for exchange or portability is limited by use and scope. We do not make every piece of data available to the practice.

Contact Information:
Dan Van Tran
233 Spring Street
New York, NY 10013, US
[email protected]
203-505-4002